// App-Quantinova.ai

TCT-400 : The importance of implantation technique in ensuring optimal outcomes after bioresorbable scaffold implantation: implications from a real-world cohort

Researchers

Presenter

  • Akihito Tanaka

Principal Investigators

  • Azeem Latib

  • Richard Jabbour

  • Hiroyoshi Kawamoto

  • Damiano Regazzoli

  • Antonio Mangieri

  • Marco Ancona

  • Francesco Giannini

  • Lorenzo Azzalini

  • Alaide Chieffo

  • Mauro Carlino

Medical Centers

  • San Raffaele Hospital, Milan, Italy

  • Columbus Hospital/San Raffaele Hospital, Milan, Milan, Italy

  • Interventional Cardiology institute San Raffaele Hospital, Soverato, Reggio Calabria, Italy

  • Unknown, London, United Kingdom

  • San Raffaele Scientific Institute/EMO-GVM Centro Cuore Columbus, Milan, Italy

  • San Raffaele Hospital, Milan, Italy

  • San Raffael Scientific Institute, Milan, Italy, Milan, Italy

  • San Raffaele Scientific Institute, Milan, Italy

  • San Raffaele Scientific Institute, Milan, Italy

  • EMO-GVM Centro Cuore Columbus, Milan, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved